Cero Therapeutics Holdings Operating Expenses Growth & History (CERO)

Cero Therapeutics Holdings's operating expenses was $19.3M for fiscal 2025.

View full Cero Therapeutics Holdings company overview

Cero Therapeutics Holdings annual operating expenses history

Cero Therapeutics Holdings annual operating expenses

Fiscal yearPeriod endedOperating expensesChangeGrowth
20252025-12-31$19.3M$4.0M+26.31%
20242024-12-31$15.3M$7.6M+99.36%
20232023-12-31$7.7M$4.8M+164.16%
20222022-12-31$2.9M$2.6M+775.05%
20212021-12-31$332,030

Cero Therapeutics Holdings operating expenses trends

Between the periods ended 2021-12-31 and 2025-12-31, Cero Therapeutics Holdings's operating expenses increased from $332,030 to $19.3M, a change of $19.0M. The latest reported quarter, Q2 2026, shows $3.8M.

About the metric

What operating expenses mean

Operating expenses are the recurring costs of running a company’s business beyond the direct costs used to calculate gross profit. They commonly include selling, general and administrative expenses, research and development, and other operating costs.

Calculation and source

SEC-reported and calculated operating expenses

TickerStat uses operating expenses reported in company SEC filings when available. When a separate total is unavailable, it calculates operating expenses as aligned gross profit minus operating income for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Cero Therapeutics Holdings source filings ↗

Community posts

It’s quiet here.

No posts about CERO yet. Start the conversation.

Write the first post